Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity.


Journal

The American surgeon
ISSN: 1555-9823
Titre abrégé: Am Surg
Pays: United States
ID NLM: 0370522

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 12 11 2021
medline: 15 12 2021
entrez: 11 11 2021
Statut: ppublish

Résumé

Well-differentiated liposarcoma (WDLPS) is a low-grade soft tissue sarcoma with a propensity for local recurrence. The necessity of obtaining microscopically free surgical margins (R0) to minimize local recurrence is not clear. This study evaluates recurrence-free survival (RFS) of extremity WDLPS in relation to resection margin status. A retrospective review of adult patients with primary extremity WDLPS at seven US institutions from 2000 to 2016 was performed. Patients with recurrent tumors or incomplete resection (R2) were excluded. Clinicopathologic factors were analyzed to assess impact on local RFS. 97 patients with primary extremity WDLPS were identified. The majority of patients had deep, lower extremity tumors. Mean tumor size was 18.2±8.9cm. Patients were treated with either radical (76.3%) or excisional (23.7%) resections; 64% had R0 and 36% had microscopically positive (R1) resection margins. Ten patients received radiation therapy with no difference in receipt of radiation between R0 vs R1 groups. Thirteen patients (13%) developed a local recurrence with no difference in RFS between R0 vs R1 resection. Five-year RFS was 59.5% for R0 vs 85.2% for R1. Only one patient died of disease after developing dedifferentiation and distant metastasis despite originally having an R0 resection. In this large multi-institutional study of surgical resection of extremity WDLPS, microscopically positive margins were not associated with an increased risk of recurrence. Positive microscopic margin resection for extremity WDLPS may yield similar rates of local control while avoiding a radical approach to obtain microscopically negative margins.

Sections du résumé

BACKGROUND BACKGROUND
Well-differentiated liposarcoma (WDLPS) is a low-grade soft tissue sarcoma with a propensity for local recurrence. The necessity of obtaining microscopically free surgical margins (R0) to minimize local recurrence is not clear. This study evaluates recurrence-free survival (RFS) of extremity WDLPS in relation to resection margin status.
METHODS METHODS
A retrospective review of adult patients with primary extremity WDLPS at seven US institutions from 2000 to 2016 was performed. Patients with recurrent tumors or incomplete resection (R2) were excluded. Clinicopathologic factors were analyzed to assess impact on local RFS.
RESULTS RESULTS
97 patients with primary extremity WDLPS were identified. The majority of patients had deep, lower extremity tumors. Mean tumor size was 18.2±8.9cm. Patients were treated with either radical (76.3%) or excisional (23.7%) resections; 64% had R0 and 36% had microscopically positive (R1) resection margins. Ten patients received radiation therapy with no difference in receipt of radiation between R0 vs R1 groups. Thirteen patients (13%) developed a local recurrence with no difference in RFS between R0 vs R1 resection. Five-year RFS was 59.5% for R0 vs 85.2% for R1. Only one patient died of disease after developing dedifferentiation and distant metastasis despite originally having an R0 resection.
DISCUSSION CONCLUSIONS
In this large multi-institutional study of surgical resection of extremity WDLPS, microscopically positive margins were not associated with an increased risk of recurrence. Positive microscopic margin resection for extremity WDLPS may yield similar rates of local control while avoiding a radical approach to obtain microscopically negative margins.

Identifiants

pubmed: 34758653
doi: 10.1177/00031348211054536
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1752-1759

Auteurs

Chelsea R Olson (CR)

Department of Surgery, 21822University of South Alabama, Mobile, AL, USA.

Lorena P Suarez-Kelly (LP)

Department of Surgery, 10624Stanford University, Palo Alto, CA, USA.

Cecilia G Ethun (CG)

Department of Surgery, 12246University of Chicago Medicine, Chicago, IL, USA.

Rita D Shelby (RD)

Department of Surgery, 10624Stanford University, Palo Alto, CA, USA.

Peter Y Yu (PY)

Department of Surgery, 10624Stanford University, Palo Alto, CA, USA.

Tasha M Hughes (TM)

Department of Surgery, 10624Stanford University, Palo Alto, CA, USA.

Marilly Palettas (M)

Department of Surgery, 10624Stanford University, Palo Alto, CA, USA.

Thuy B Tran (TB)

Department of Surgery, 12280Wake Forest University, Winston-Salem, NC, USA.

George Poultsides (G)

Department of Surgery, 12280Wake Forest University, Winston-Salem, NC, USA.

Jennifer Tseng (J)

Department of Surgery, 12275Washington University School of Medicine, St. Louis, MO, USA.

Kevin K Roggin (KK)

Department of Surgery, 12275Washington University School of Medicine, St. Louis, MO, USA.

Konstantinos Chouliaras (K)

Department of Surgery, 5506Medical College of Wisconsin, Milwaukee, WI, USA.

Konstantinos Votanopoulos (K)

Department of Surgery, 5506Medical College of Wisconsin, Milwaukee, WI, USA.

Bradley A Krasnick (BA)

Department of Surgery, 12306The Ohio State University, Columbus, OH, USA.

Ryan C Fields (RC)

Department of Surgery, 12306The Ohio State University, Columbus, OH, USA.

David M King (DM)

Department of Surgery, 23034Emory University, Atlanta, GA, USA.

Meena Bedi (M)

Department of Surgery, 23034Emory University, Atlanta, GA, USA.

Raphael E Pollock (RE)

Department of Surgery, 12306The Ohio State University, Columbus, OH, USA.

Valerie P Grignol (VP)

Department of Surgery, 10624Stanford University, Palo Alto, CA, USA.

Kenneth Cardona (K)

Department of Surgery, 12246University of Chicago Medicine, Chicago, IL, USA.

J Harrison Howard (JH)

Department of Surgery, 21822University of South Alabama, Mobile, AL, USA.
Department of Surgery, 10624Stanford University, Palo Alto, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH